ANIK Anika Therapeutics Inc
Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
$39.84 -0.64 (-1.58%)
As of 04/09/2021 15:59:44 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 02/06/2001
Outstanding shares: 14,329,618
Average volume: 208,893
Market cap: $570,318,796
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 035255108
ISIN: US0352551081
Sedol: 2035754
Valuation (See tab for details)
PE ratio: -23.78
PB ratio: 2.09
PS ratio: 4.37
Return on equity: -8.80%
Net income %: -18.38%